ReviewFrontiers in pharmacology2019

Sphingosine 1-Phosphate Receptors and Metabolic Enzymes as Druggable Targets for Brain Diseases.

Sara Grassi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.